About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Evaluation of a Novel Human Milk Fortifier in Preterm Infants

Evaluation of a Novel Human Milk Fortifier in Preterm Infants

NCT01373073·15 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Abbott Nutrition

Age

0–0

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

700-1500g birth weight
33 weeks or less gestational age
Appropriate for gestational age
Initiate enteral feeds of human milk by 21 days of life
Mother provided exclusive human milk feeds
Parents allow both human milk and study human milk fortifier
Singleton or twin birth

You may not be if

Feeding preterm infant formula or non-study human milk fortifier
Expected at facility less than 15 days
Congenital anomalies/disease affecting growth and development
5 minute APGAR of 4 or less
Steroid use
ECMO
Grade III or IV PVH/IVH
Mechanical ventilator dependency
Maternal incapacity
History of major surgery
Asphyxia
Confirmed NEC or sepsis
Use of probiotics

The record

StatusCompleted

PhasePhase 3

Taking part147

StartedAug 2011

UpdatedFeb 20, 2013

Conditions

Preterm Infants

Where15

University of Alabama
Birmingham, Alabama, United States
UCSD Medical Center
San Diego, California, United States
University South Florida
Tampa, Florida, United States